1. Home
  2. CRMD vs HPP Comparison

CRMD vs HPP Comparison

Compare CRMD & HPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRMD
  • HPP
  • Stock Information
  • Founded
  • CRMD 2006
  • HPP 1997
  • Country
  • CRMD United States
  • HPP United States
  • Employees
  • CRMD N/A
  • HPP N/A
  • Industry
  • CRMD Biotechnology: Pharmaceutical Preparations
  • HPP Real Estate
  • Sector
  • CRMD Health Care
  • HPP Finance
  • Exchange
  • CRMD Nasdaq
  • HPP Nasdaq
  • Market Cap
  • CRMD 877.5M
  • HPP 1.0B
  • IPO Year
  • CRMD 2010
  • HPP 2010
  • Fundamental
  • Price
  • CRMD $11.64
  • HPP $2.40
  • Analyst Decision
  • CRMD Strong Buy
  • HPP Hold
  • Analyst Count
  • CRMD 7
  • HPP 11
  • Target Price
  • CRMD $17.33
  • HPP $3.09
  • AVG Volume (30 Days)
  • CRMD 1.8M
  • HPP 5.8M
  • Earning Date
  • CRMD 08-13-2025
  • HPP 08-05-2025
  • Dividend Yield
  • CRMD N/A
  • HPP N/A
  • EPS Growth
  • CRMD N/A
  • HPP N/A
  • EPS
  • CRMD 0.28
  • HPP N/A
  • Revenue
  • CRMD $82,553,827.00
  • HPP $818,699,000.00
  • Revenue This Year
  • CRMD $278.96
  • HPP N/A
  • Revenue Next Year
  • CRMD $45.85
  • HPP $5.68
  • P/E Ratio
  • CRMD $41.93
  • HPP N/A
  • Revenue Growth
  • CRMD N/A
  • HPP N/A
  • 52 Week Low
  • CRMD $3.61
  • HPP $1.78
  • 52 Week High
  • CRMD $17.43
  • HPP $6.09
  • Technical
  • Relative Strength Index (RSI)
  • CRMD 47.40
  • HPP 37.87
  • Support Level
  • CRMD $11.40
  • HPP $2.41
  • Resistance Level
  • CRMD $12.02
  • HPP $2.50
  • Average True Range (ATR)
  • CRMD 0.47
  • HPP 0.12
  • MACD
  • CRMD 0.10
  • HPP -0.04
  • Stochastic Oscillator
  • CRMD 68.61
  • HPP 4.50

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

About HPP Hudson Pacific Properties Inc.

Hudson Pacific Properties Inc is a real estate investment trust that acquires, operates, and owns office buildings and media and entertainment properties, such as sound stages, on America's West Coast. The company focuses on developed, urban markets in Northern California, Southern California, and the Pacific Northwest. In terms of total square footage, the vast majority of Hudson Pacific's real estate portfolio is composed of office properties located in the Greater Seattle, San Francisco, and Los Angeles areas. The company operates in two reportable segments; office properties & related operations; and studio properties & related operations. The majority of revenue is derived from the office properties & related operations segment.

Share on Social Networks: